SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹10 Cr | ₹8.57 Cr | ₹7.09 Cr | ₹6.83 Cr | ₹6.40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SAKAR HEALTHCARE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹10 Cr |
Mar2023 | ₹8.57 Cr |
Mar2022 | ₹7.09 Cr |
Mar2021 | ₹6.83 Cr |
Mar2020 | ₹6.40 Cr |
How is Deferred Tax Assets / Liabilities of SAKAR HEALTHCARE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹10 Cr | 16.94 | |
Mar2023 | ₹8.57 Cr | 20.87 | |
Mar2022 | ₹7.09 Cr | 3.88 | |
Mar2021 | ₹6.83 Cr | 6.75 | |
Mar2020 | ₹6.40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹628.9 Cr | -5.6% | -1.5% | -17.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -5.6% |
-1.5% |
-17.5% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses